SomnoMed Ltd SOM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.32
- Day Range
- A$0.29–0.30
- 52-Week Range
- A$0.29–0.95
- Bid/Ask
- A$0.29 / A$0.35
- Shares Outstanding
- 219.77M
- Market Cap
- A$63.73M
- Volume/Avg
- 62,956 / 114,008
Key Statistics
- Price/Earnings (Normalized)
- 50.74
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
SomnoMed Ltd is a public company providing treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux and SomTab. It produces and sells devices for the oral treatment of sleep-related disorders mainly in Asia Pacific, North America and Europe, with maximum revenue generated from Europe.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 22
- Website
- https://www.somnomed.com.au
Valuation
|
Metric
|
SOM
|
|---|---|
Price/Earnings (Normalized) | 50.74 |
Price/Book Value | 1.33 |
Price/Sales | 0.54 |
Price/Cash Flow | 7.42 |
Price/Earnings
SOM
Financial Strength
|
Metric
|
SOM
|
|---|---|
Quick Ratio | 1.24 |
Current Ratio | 1.67 |
Interest Coverage | −0.17 |
Quick Ratio
SOM
Profitability
|
Metric
|
SOM
|
|---|---|
Return on Assets (Normalized) | −2.47% |
Return on Equity (Normalized) | −4.05% |
Return on Invested Capital (Normalized) | −3.07% |
Return on Assets
SOM
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|m&%<g! | LOCK|MCGT> | $169B | |||
| Medtronic PLC
MDT
| LOCK|S>&^#P | LOCK|r<XsF | $110B | |||
| Stryker Corp
SYK
| LOCK|%$!lxl> | LOCK|v& | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|tB??p# | LOCK|&>s! | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|kB!$F&^ | LOCK|M?C% | $49B | |||
| DexCom Inc
DXCM
| LOCK|!bGKpTJ | LOCK|g?$z^ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|ltPCh! | LOCK|##L | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|x% | LOCK|k^ | $23B | |||
| Steris PLC
STE
| LOCK|#%S#nY | LOCK|RW$r | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|Cczj!l^ | LOCK|Z^ | $17B |
United States